Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Bapotulimab (Synonyms: BAY-1905254, BAY1905254)

Catalog No. T78304 Copy Product Info
Purity: 95%
🥰Excellent
Bapotulimab (BAY-1905254) is a human/mouse/monkey cross-reactive monoclonal antibody that targets and inhibits ILDR2 (immunoglobulin-like domain containing receptor 2), blocking its immunosuppressive activity for cancer immunotherapy. Bapotulimab promotes T-cell activation in mice, enhancing antigen-specific T-cell proliferation and cytotoxicity.

Bapotulimab

Copy Product Info
🥰Excellent
Catalog No. T78304
Synonyms BAY-1905254, BAY1905254

Bapotulimab (BAY-1905254) is a human/mouse/monkey cross-reactive monoclonal antibody that targets and inhibits ILDR2 (immunoglobulin-like domain containing receptor 2), blocking its immunosuppressive activity for cancer immunotherapy. Bapotulimab promotes T-cell activation in mice, enhancing antigen-specific T-cell proliferation and cytotoxicity.

Bapotulimab
Cas No. 2359413-58-2
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$378-In Stock
5 mg$993-In Stock
10 mg$1,590-In Stock
25 mg$2,350-In Stock
50 mg$3,180-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.8% (SDS-PAGE); 97.8% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Bapotulimab (BAY-1905254) is a human/mouse/monkey cross-reactive monoclonal antibody that targets and inhibits ILDR2 (immunoglobulin-like domain containing receptor 2), blocking its immunosuppressive activity for cancer immunotherapy. Bapotulimab promotes T-cell activation in mice, enhancing antigen-specific T-cell proliferation and cytotoxicity.
In vitro
Bapotulimab inhibits the immunosuppressive effect of ILDR2 on T cell activation. This agent exhibits cross-reactivity between humans and mice, attributed to a 98% sequence identity in the extracellular domain between human and murine orthologs of ILDR2 [1]. Bapotulimab (BAY-1905254; at concentrations of 5, 25, 100, or 500 ng/mL) enhances T cell activation and promotes the proliferation of antigen-specific T cells in vitro [1].
In vivo
Bapotulimab (BAY-1905254; 10 mg/kg; intraperitoneal injection; administered on days 1 and 4) demonstrated a significant increase in antigen-specific T-cell proliferation and cytotoxicity [1].
SynonymsBAY-1905254, BAY1905254
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetILDR2
Chemical Properties
Molecular Weight144.97 kDa
Cas No.2359413-58-2
Antibody Information
IsotypeHuman IgG2 kappa
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Keywords

Related Tags: buy Bapotulimab | purchase Bapotulimab | Bapotulimab cost | order Bapotulimab | Bapotulimab in vivo | Bapotulimab in vitro | Bapotulimab molecular weight